Pharma Company And Drug Testing Industry Claim Trump's Rescheduling Move Will 'Increase Marijuana Abuse'
Pharmaceutical and drug testing industries warn that President Trump's marijuana rescheduling move could lead to increased drug abuse.
📍 Where it landed
Federal marijuana rescheduling hearings concluded with a DEA judge outlining the next steps. While some pharma and drug testing groups claimed the move would increase marijuana abuse, other witnesses conceded that regulation reduces crime.
The story quieted without a definitive conclusion in the coverage.
Epilogue added 96d ago, after coverage quieted.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
- Velocity & Diffusion: Coverage escalated across 4 distinct news outlets with 7 published articles, achieving a live velocity of 4.
- Primary Driver: Pharmaceutical and drug testing industries warn that President Trump's marijuana rescheduling move could lead to increased drug abuse.
- Predictive Outlook: Newsylist algorithmic models forecast this story will remain a dominant headline through tomorrow.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
Federal marijuana rescheduling hearings have concluded, with a DEA judge outlining the next steps in the process. While cannabis industry operators and some state witnesses expressed encouragement—noting that regulation can reduce crime—pharmaceutical and drug testing companies have raised concerns regarding a potential increase in marijuana abuse.
Coverage from Marijuana Moment, MJBizDaily, and Business of Cannabis focuses on the outcomes of the DEA hearings and the diverging reactions between the cannabis sector and anti-cannabis groups. The Motley Fool is analyzing the potential impact of the move on specific companies, including Canopy Growth, Green Thumb, and Tilray.
Future developments center on the next steps laid out by the DEA judge and the legal battle regarding whether marijuana companies can join lawsuits to defend the rescheduling effort.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 96d ago.
The reporting (7)
-
Federal Marijuana Rescheduling Hearing Wraps Up, With DEA Judge Laying Out Next Steps Marijuana Moment · 99d ago broke it first
-
-
-
-
-
-
Quick answers
Who is opposing the rescheduling move?
Pharmaceutical companies, the drug testing industry, and anti-cannabis groups are among those opposing the move.
What was the reaction of the cannabis industry to the hearings?
According to MJBizDaily, the cannabis industry is encouraged following the conclusion of the DEA rescheduling hearings.
Which companies are being monitored for the impact of this move?
The Motley Fool is tracking what the rescheduling means for Canopy Growth, Green Thumb, and Tilray.
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
People, places & organizations
Topics
From around our network
- What Trump's Housing Order Means for a $360,000 Loan at 7.32% daybreakwire.com
Related trends
Trump resists AI slowdown as the political tide turns
Trump resists slowing down artificial intelligence development, diverging from leading tech executives and expert warnings.
Trump says he plans to remove a 10% tariff on Irish whiskey
Plans to remove a tariff on Irish whiskey are generating widespread attention across multiple news outlets.
Court Strikes Down Trump Order to Keep an Aging Coal-Burning Plant Running
A federal court has blocked an order to keep an aging Michigan coal plant running, delivering a blow to revival efforts.
‘South Park’ Is “Changing Its Name” to ‘South America’ for Season 29 to Mock Trump
The animated series 'South Park' has been renamed 'South America' for its upcoming 29th season to mock the Trump administration.
Stock Market Today: Dow falls 350 points, S&P 500 and Nasdaq lower as Trump threatens fresh Iran strikes; Brent oil tops $90 and 30-year yields hits 5.25%
Trump’s Iran threat sparks a 350‑point Dow plunge, yet tech stocks like Nvidia climb, fueling a market paradox.
Dolly Parton Died After Brief Battle With Cancer
The music world mourns Dolly Parton, whose death from cancer ignites tributes, legacy projects, and a national flag salute.